Literature DB >> 20464136

Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors.

Rafaela Gomes Andrade1, Maísa Aparecida Ribeiro, Maria Sueli Silva Namen-Lopes, Sônia Mara Nunes Silva, Fernando Valadares Basques, João Gabriel Ribas, Anna Bárbara de Freitas Carneiro-Proietti, Marina Lobato Martins.   

Abstract

INTRODUCTION: HTLV-1/2 screening among blood donors commonly utilizes an enzyme-linked immunosorbent assay (EIA), followed by a confirmatory method such as Western blot (WB) if the EIA is positive. However, this algorithm yields a high rate of inconclusive results, and is expensive.
METHODS: Two qualitative real-time PCR assays were developed to detect HTLV-1 and 2, and a total of 318 samples were tested (152 blood donors, 108 asymptomatic carriers, 26 HAM/TSP patients and 30 seronegative individuals).
RESULTS: The sensitivity and specificity of PCR in comparison with WB results were 99.4% and 98.5%, respectively. PCR tests were more efficient for identifying the virus type, detecting HTLV-2 infection and defining inconclusive cases.
CONCLUSIONS: Because real-time PCR is sensitive and practical and costs much less than WB, this technique can be used as a confirmatory test for HTLV in blood banks, as a replacement for WB.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20464136     DOI: 10.1590/s0037-86822010000200001

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  14 in total

1.  A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiological determinants and PCR results in central African inhabitants.

Authors:  Claudia Filippone; Sylviane Bassot; Edouard Betsem; Patricia Tortevoye; Micheline Guillotte; Odile Mercereau-Puijalon; Sabine Plancoulaine; Sara Calattini; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?

Authors:  Marina Lobato Martins; Jacqueline Cronemberger Guimarães; João Gabriel Ribas; Luiz Cláudio Ferreira Romanelli; Anna Bárbara de Freitas Carneiro-Proietti
Journal:  J Neurovirol       Date:  2016-09-27       Impact factor: 2.643

3.  Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009.

Authors:  Anna Bárbara F Carneiro-Proietti; Ester C Sabino; Silvana Leão; Nanci A Salles; Paula Loureiro; Moussa Sarr; David Wright; Michael Busch; Fernando A Proietti; Edward L Murphy
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-03       Impact factor: 2.205

4.  Cognitive screening in HTLV-1-infected people using a self-perceived memory score and auditory P300.

Authors:  Aline Rejane Rosa de Castro; Ludimila Labanca; Luciana Macedo de Resende; Marjore Rhaissa de Sousa; Rafael Teixeira Scoralick Dias; Júlia Fonseca de Morais Caporali; Denise Utsch-Gonçalves
Journal:  J Neurovirol       Date:  2022-02-15       Impact factor: 2.643

5.  Rapid and Sensitive Qualitative Duoplex Real-Time PCR Method for Discriminatory and Confirmatory Diagnosis of HTLV-1 and HTLV-2 Infections: Brazilian Multicentric Study.

Authors:  Mauricio Cristiano Rocha-Junior; Evandra Strazza Rodrigues; Svetoslav Nanev Slavov; Tatiane Assone; Maíra Pedreschi; Debora Glenda Lima de La Roque; Maisa Sousa; Viviana Olavarria; Bernardo Galvão-Castro; Benedito Antonio Lopes da Fonseca; Augusto César Penalva de Oliveira; Jerusa Smid; Oswaldo Massaiti Takayanagui; Jorge Casseb; Dimas Tadeu Covas; Simone Kashima
Journal:  Front Med (Lausanne)       Date:  2022-06-09

6.  HTLV-1 proviral load in cerebrospinal fluid may not be a good marker to differentiate asymptomatic carriers with high proviral load in blood from HAM/TSP patients.

Authors:  Marina Lobato Martins; Anna Bárbara de Freitas Carneiro-Proietti; Rodrigo Nicolato; Débora Marques de Miranda; Luiz Cláudio Ferreira Romanelli
Journal:  J Neurovirol       Date:  2018-03-27       Impact factor: 2.643

7.  Prevalence of human T-lymphotropic virus 1/2 in Nigeria's capital territory and meta-analysis of Nigerian studies.

Authors:  Nneoma Confidence JeanStephanie Anyanwu; Elijah Ekah Ella; Maryam Aminu; Maleeha Azam; Muhammad Ajmal; Haruna Makonjuola Kazeem
Journal:  SAGE Open Med       Date:  2019-04-16

8.  Vestibular-evoked myogenic potential triggered by galvanic vestibular stimulation may reveal subclinical alterations in human T-cell lymphotropic virus type 1-associated myelopathy.

Authors:  Ludimila Labanca; Júlia Fonseca de Morais Caporali; Sirley Alves da Silva Carvalho; José Roberto Lambertucci; Anna Bárbara de Freitas Carneiro Proietti; Luiz Cláudio Ferreira Romanelli; Paul Avan; Fabrice Giraudet; Bárbara Oliveira Souza; Kyonis Rodrigues Florentino; Denise Utsch Gonçalves
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

Review 9.  Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders.

Authors:  Giovanni Di Minno; Carlo Federico Perno; Andreas Tiede; David Navarro; Mariana Canaro; Lutz Güertler; James W Ironside
Journal:  Blood Rev       Date:  2015-07-20       Impact factor: 8.250

10.  Prevalence of human T-lymphotropic virus type 1 and 2 (HTLV-1/-2) infection in pregnant women in Brazil: a systematic review and meta-analysis.

Authors:  Bruna Angelo Vieira; Augusto Bacelo Bidinotto; William Jones Dartora; Luana Giongo Pedrotti; Vanessa Martins de Oliveira; Eliana Márcia Wendland
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.